Acasti Pharma reported $69.8M in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Acasti Pharma USD 69.8M 8.58M Jun/2025
Addus HomeCare USD 1.41B 1.35M Jun/2025
Amarin USD 655.68M 29.67M Mar/2025
Cassava Sciences USD 135.38M 22.15M Jun/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Option Care Health USD 3.38B 74.31M Jun/2025
Organigram Holdings CAD 564.62M 85.41M Jun/2025
Tilray USD 4.19B 70.11M Nov/2024